Cargando…
Wilms Tumor-1 (WT1) rs16754 Polymorphism
Autores principales: | Sookaromdee, Pathum, Wiwanitkit, Viroj |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Galenos Publishing
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373512/ https://www.ncbi.nlm.nih.gov/pubmed/30520285 http://dx.doi.org/10.4274/tjh.galenos.2018.2018.0407 |
Ejemplares similares
-
Wilms Tumor-1 (WT1) rs16754 Polymorphism and Clinical Outcome in Acute Myeloid Leukemia
por: Ramzi, Mani, et al.
Publicado: (2019) -
The Wilms Tumor-1 (WT1) rs16754 polymorphism is a prognostic factor in acute myeloid leukemia (AML): a meta-analysis
por: Long, Jianting, et al.
Publicado: (2016) -
Association between the Wilms tumor-1 rs16754 polymorphism and acute myeloid leukemia: A MOOSE-compliant meta-analysis
por: Yu, Xin, et al.
Publicado: (2020) -
TGF-Β1, PNPLA3 Genetic Variants and the Risk of Hepatic Fibrosis: Correspondence
por: Sookaromdee, Pathum, et al.
Publicado: (2021) -
WT1 Gene Mutations, rs16754 Variant, and WT1 Overexpression as Prognostic Factors in Acute Myeloid Leukemia Patients
por: Koczkodaj, Dorota, et al.
Publicado: (2022)